Cathie's Ark Logo
undefined Logo

ARKG Holdings of Intellia Therapeutics (NTLA) - Updated Daily

Gene TherapyGenomicsSynthetic BiologyGene Base EditingCRSPR Gene Editing
Date
Direction
Shares
Fund Weight
Fund
September 3, 2024
BUY36.086k0.0584%ARKG
August 30, 2024
BUY20.610k0.0333%ARKG
August 21, 2024
BUY61.186k0.1017%ARKG
August 20, 2024
BUY122.311k0.1986%ARKG
August 19, 2024
BUY30.164k0.0488%ARKG

Key Statistics

⚖️Weighting🧢Market Cap
0.06%$1.81b
🏋🏿‍♂️Weight Rank In ARKG🌏Country
23🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
153$54.51
🎫ARK Ownership Percent
0.04%

Other ETFs That Hold NTLA

Ticker
NameWeight
ARKGARK Genomic Revolution ETF3.95%
ARKKARK Innovation ETF3.77%
GNOMGlobal X Genomics & Biotechnology ETF3.28%
XBISPDR® S&P Biotech ETF1.12%
IBBiShares Biotechnology ETF0.31%
LABUS&P Biotech Bull 3X Shares ETF0.24%

Research Notes and Commentary for NTLA

No Research Notes Found for NTLA